October 16, 2025 – (press release) – Tulane Ventures, an early-stage investment fund launched by the Tulane University Innovation Institute, has invested $250,000 in Exactics, a biotech startup co-founded by Tulane senior Dylan Murray. The company is developing multiple at-home tests for infectious diseases, starting with a rapid test that will allow users to determine if a tick carries the pathogen that causes Lyme disease.
In a biotech field dominated by seasoned researchers, Exactics is showing that undergraduates can also develop fast, practical solutions to urgent health challenges. The startup was founded by students from the University of Chicago and Tulane. Its flagship product, the TiCK Test, works like an at-home COVID-19 test.